Succinate dehydrogenase-deficient GISTs: A clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age

American Journal of Surgical Pathology

Volumn 35, Issue 11, 2011, Pages 1712-1721

  Miettinen, Markku ^a,b   Wang, Zeng Feng ^a   Sarlomo Rikala, Maarit ^c   Osuch, Czeslaw ^d   Rutkowski, Piotr ^e   Lasota, Jerzy ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOINT PATHOLOGY CENTER   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d JAGIELLONIAN UNIVERSITY   (Poland)

^e INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

gastrointestinal stromal tumor; prognosis; SDHB; succinate dehydrogenase; succinate dehydrogenase subunit B

Indexed keywords

SDHB PROTEIN, HUMAN; SUCCINATE DEHYDROGENASE; TUMOR MARKER;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CHEMISTRY; CHILD; CLINICAL TRIAL; ENZYMOLOGY; FEMALE; FINLAND; GASTROINTESTINAL STROMAL TUMOR; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; MIDDLE AGED; MITOSIS INDEX; MORTALITY; MULTICENTER STUDY; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLAND; PROGNOSIS; STOMACH TUMOR; TIME; TUMOR VOLUME; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; FINLAND; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MARYLAND; MIDDLE AGED; MITOTIC INDEX; NEOPLASM INVASIVENESS; POLAND; PROGNOSIS; STOMACH NEOPLASMS; SUCCINATE DEHYDROGENASE; TIME FACTORS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80055020285     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182260752     Document Type: Article

References (38)

1. Agaram NP, Laquaglia MP, Ustum B, et al. Molecular characterization of pediatric gastrointestinal tumors. Clin Cancer Res. 2008;14:3204-3215.
2. Agaram NP, Wong GC, Guo T, et al. Novel BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors. Genes Chromosomes Cancer. 2008;47:853-859.
3. Burnichon N, Rohmer V, Amar L, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94:2817-2827.
4. Burnichon N, Briere JJ, Libe R, et al. SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 2010;19:3011-3020.
5. Carney JA. Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. J Clin Endocrinol Metab. 2009;94:3656-3662.
6. Cervera AM, Apostolova N, Crespo FL, et al. Cells silenced for SDHB expression display characteristic features of the tumor phenotype. Cancer Res. 2008;68:4058-4067.
7. Dahia PLM, Ross KN, Wright ME, et al. A HIF regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genet. 2005;1:72-79.
8. Gaal J, Stratakis CA, Carney JA, et al. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod Pathol. 2011;24:147-151.
9. Gill AJ, Benn DE, Chou A, et al. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromo-cytoma syndromes. Hum Pathol. 2010;34: 636-644.
10. Gill AJ, Chou A, Vilain R, et al. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol. 2010;34:805-814.
11. Gimenez-Roqueplo AP, Favier J, Rustin P, et al. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet. 2001;69:1186-1197. (Pubitemid 33124200)
12. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299: 708-710. (Pubitemid 36159485)
13. Hes FJ, Weiss MM, Woortman SA, et al. Low penetrance of a SDHB mutation in a large Dutch paraganglioma family. BMC Med Genet. 2010;11:92-97.
14. Hirota S, Isozaki K, Moriyama Y, et al. Gain-of-function mutations of c-kit gene in gastrointestinal stromal tumors. Science. 1998;279:577-580. (Pubitemid 28067289)
15. Horvath R, Abicht A, Holinski-Feder E, et al. Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA). J Neurol Neurosurg Psychiatry. 2006;77:74-76. (Pubitemid 43022696)
16. Hostein I, Faur N, Primois C, et al. BRAF mutation status in gastrointestinal stromal tumors. Am J Clin Pathol. 2010;133:141-148.
17. Janeway KA, Kim SY, Lodish M, et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci USA. 2011;108:314-318.
18. King A, Selak MA, Gottlieb E. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene. 2006;25:4675-4682. (Pubitemid 44187617)
19. Kinoshita K, Hirota S, Isozaki K, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol. 2004;202:80-85. (Pubitemid 38072848)
20. Lasota J, Miettinen M. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours. Histopathology. 2008;53:245-266.
21. Matyakhina L, Bei TA, McWhinney SR, et al. Genetics of Carney triad: recurrent losses of chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab. 2007;92:2938-2943. (Pubitemid 47236353)
22. McWhinney SR, Pasini B, Stratakis CA. Familial gastrointestinal stromal tumors and germ-line mutations. N Engl J Med. 2007;357: 1054-1056. (Pubitemid 47367102)
23. Miettinen M, Paal E, Lasota J, et al. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 32 cases. Am J Surg Pathol. 2002;26:301-311. (Pubitemid 34184453)
24. Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature. Am J Surg Pathol. 2005;29:1373-1381. (Pubitemid 41368774)
25. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52-68. (Pubitemid 40023952)
26. Pantaleo MA, Astolfi A, Indio V, et al. SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing. J Natl Cancer Inst. 2011;103:1-5.
27. Pasini B, McWhinney SR, Bei T, et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet. 2008;16:79-88. (Pubitemid 350284184)
28. Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaechromocytomaparaganglioma syndromes. J Int Med. 2009;266:19-42.
29. Perry CG, Young WF, McWhinney SR, et al. Functioning paraganglioma and gastrointestinal stromal tumor of the jejunum in three women: syndrome or coincidence. Am J Surg Pathol. 2006;30: 42-49. (Pubitemid 43740208)
30. Pollard PJ, Briere JJ, Alam NA, et al. Accumulation of Krebs cycle intermediates and over-expression of HIF1 a in tumours which result from germline FH and SDH mutations. Hum Mol Genet. 2005;14:2231-2239. (Pubitemid 41418022)
31. Prakash S, Sarran L, Socci N, et al. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. J Pediatr Hematol Oncol. 2005;27:179-187. (Pubitemid 40604837)
32. Rege TA, Wagner AJ, Corless CL, et al. "Pediatric type" gastrointestinal stromal tumors in adults: distinctive histology predicts genotype and clinical behavior. Am J Surg Pathol. 2011;35:494-504.
33. Rutter R, Winge DR, Shiffman JD. Succinate dehydrogenase: assembly, regulation and role in human disease. Mitochondrion. 2010;10:393-401.
34. Stratakis CA, Carney JA. The triad of paragangliomas, gastric stromal tumours, and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications. J Int Med. 2009;266:43-52.
35. van Nederveen FH, Gaal J, Favier J, et al. An immunohistochemical procedure to detect patients with paraganglioma and pheochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncol. 2009;10: 764-771.
36. Vanharanta S, Buchta M, McWhinney SR, et al. Early onset renal cell carcinoma as a novel extraparaganglial component of SDHBassociated heritable paraganglioma. Am J Hum Genet. 2004;74: 153-159. (Pubitemid 38085246)
37. Wang JH, Lasota J, Miettinen M. Succinate dehydrogenase subunit B (SDHB) is expressed in neurofibromatosis 1-associated gastrointestinal stromal tumors (GISTs): implications for the SDHB expression based classification of GISTs. J Cancer. 2011;2:90-93.
38. Zhang L, Smyrk TC, Young WF, et al. Gastric stromal tumors in Carney triad are different clinically, pathologically, and behaviorally from sporadic gastric gastrointestinal stromal tumors: findings in 104 cases. Am J Surg Pathol. 2010;34:53-64.